Home › Trial NCT07884201
Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant Treatment
- Trial IDNCT07884201
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorFudan University
- Enrollment572
- Start date2026-11-08
- ConditionsBreast Cancer · TNBC - Triple-Negative Breast Cancer · Immunotherapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.